Spurdle Amanda B, Hopper John L, Chen Xiaoqing, McCredie Margaret R E, Giles Graham G, Newman Beth, Chenevix-Trench Georgia
Cancer and Cell Biology Division, Joint Experimental Oncology Programme, Queensland Institute of Medical Research, and University of Queensland, Brisbane, Australia.
Lancet. 2002 Sep 21;360(9337):925-6. doi: 10.1016/S0140-6736(02)11043-9.
A C to T transition within the 3' untranslated region of the prohibitin gene alters mRNA function, and an association between the T allele and an increased risk of breast cancer has been reported in North American women, specifically in those aged under 50 years with a first-degree family history of breast cancer. We did a population-based case-control study to assess whether this association existed in Australian women. We did not note such an association in our sample of 1446 patients and 786 controls (odds ratio 0.96, 95% CI 0.80-1.16; p=0.7), or in subgroups defined by age or family history, or both. Hence, our results do not lend support to the hypothesis that this polymorphism contributes to risk of breast cancer.
prohibitin基因3'非翻译区内的C到T转换改变了mRNA功能,并且在北美女性中报道了T等位基因与乳腺癌风险增加之间的关联,特别是在那些年龄小于50岁且有乳腺癌一级家族史的女性中。我们进行了一项基于人群的病例对照研究,以评估这种关联在澳大利亚女性中是否存在。在我们的1446例患者和786例对照样本中,我们未发现这种关联(优势比0.96,95%可信区间0.80 - 1.16;p = 0.7),在按年龄或家族史或两者定义的亚组中也未发现。因此,我们的结果不支持这种多态性导致乳腺癌风险增加这一假说。